Evidence map›Paper›PMID 41868342›Full record

ArticleRSC advances2026

Controlled formation of versatile methylated compounds based on ring opening of 4-methyl-1-siloxy-1,4-epoxy-1,4-dihydrobenzene.

Takaaki Aijima, Jin Tokunaga, Sota Yoshimura, Yuki Itabashi, Tsunayoshi Takehara, Takeyuki Suzuki, Shuji Akai, Yoshinari Sawama

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Takaaki AijimaGraduate School of Pharmaceutical Sciences, The University of Osaka 1-6 Yamada-oka Suita Osaka 565-0871 Japan.
Jin TokunagaGraduate School of Pharmaceutical Sciences, The University of Osaka 1-6 Yamada-oka Suita Osaka 565-0871 Japan.
Sota YoshimuraGraduate School of Pharmaceutical Sciences, The University of Osaka 1-6 Yamada-oka Suita Osaka 565-0871 Japan.
Yuki ItabashiInstitute for Open and Transdisciplinary Research Initiative (OTRI), The University of Osaka 1-6 Yamada-oka Suita Osaka 565-0871 Japan.ORCID https://orcid.org/0000-0002-5418-156X
Tsunayoshi TakeharaSANKEN, The University of Osaka 8-1 Mihogaoka Ibaraki Osaka 567-0047 Japan.
Takeyuki SuzukiSANKEN, The University of Osaka 8-1 Mihogaoka Ibaraki Osaka 567-0047 Japan.ORCID https://orcid.org/0000-0002-2137-0276
Shuji AkaiGraduate School of Pharmaceutical Sciences, The University of Osaka 1-6 Yamada-oka Suita Osaka 565-0871 Japan.ORCID https://orcid.org/0000-0001-9149-8745
Yoshinari SawamaGraduate School of Pharmaceutical Sciences, The University of Osaka 1-6 Yamada-oka Suita Osaka 565-0871 Japan.ORCID https://orcid.org/0000-0002-9923-2412

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report an FeCl

Identifiers

PMID41868342
PMCPMC13001159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.